Corpus Intelligence IC Memo — HARRISBURG MEDICAL CENTER INC. 2026-04-26 08:08 UTC
IC Memo — HARRISBURG MEDICAL CENTER INC.
Investment Committee Memorandum | IL | 40 beds | Grade C | EBITDA uplift $3.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HARRISBURG MEDICAL CENTER INC.

CCN 140210 | SALINE, IL | 40 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HARRISBURG MEDICAL CENTER INC. is a 40-bed rural/critical access in SALINE, IL with $49.3M in net patient revenue and a -13.8% operating margin. The hospital serves a payer mix of 47.9% Medicare, 1.4% Medicaid, and 50.7% commercial.

Thesis: Turnaround. Our ML models identify $3.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.8% to -6.4% (+736bps).

Net Revenue HCRIS$49.3M
Current EBITDA COMPUTED$-6.8M
Operating Margin COMPUTED-13.8%
Occupancy HCRIS13.3%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS40.0%
Distress Probability ML57.6%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
76
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of -13.8% places it below the state median. Among 76 size-comparable peers (20-80 beds), the median margin is -3.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 76 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HARRISBURG MEDICAL CENTER INC (Target)IL40$49.3M-13.8%
MIDWESTERN REGIONAL MEDICAL CEIL73$1.38B80.5%
KATHERINE SHAW BETHEA HOSPITALIL66$136.9M-12.8%
PROCTOR HOSPITALIL72$133.9M34.9%
GIBSON AREA HOSPITAL AND HEALTIL25$125.0M-6.7%
GRAHAM HOSPITAL ASSOCIATIONIL43$105.0M-4.7%
PARIS COMMUNITY HOSPITALIL25$100.7M-4.2%
OSF SAINT ANTHONYS HEALTH CENTIL49$91.4M-9.8%
ST. MARGARETS HEALTH - SPRING IL44$88.1M-12.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$986K+200bp12mo
Denial Rate Reduction12.0%6.5%$976K+198bp12mo
A/R Days Reduction5200.0%3800.0%$600K+122bp9mo
Clean Claim Rate88.0%96.0%$32K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$986K
Denial Rate Reduction
$976K
A/R Days Reduction
$600K
Clean Claim Rate
$32K
Total EBITDA Uplift$3.6M
Current EBITDA$-6.8M
+ RCM Uplift+$3.6M
Pro Forma EBITDA$-3.2M
Current Margin-13.8%
Pro Forma Margin-6.4%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-10.5M$-8.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-10.5M$-12.8M0.00x-100.0%
Bull Case9.0x11.0x$-9.4M$-4.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-9.4M$-7.4M0.00x-100.0%
Bear Case11.0x10.0x$-11.5M$-23.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-11.5M$-29.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 13.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 76 hospitals with 20-80 beds
  • Same-state prioritization (n=77)
  • Comp margins: P25=-8.8% / P50=-3.0% / P75=8.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.